Everlum Bio tackles rare childhood diseases

Everlum Bio tackles rare childhood diseases

Oct 12, 2022 | Press & Recognition

200 million children live with a rare disease, but only 5% of those diseases have treatments available. ACC Bioscience Incubator member company Everlum Bio has set out to change these stats by developing proof-of-concept therapeutics for rare genetic diseases. Since...